Ahmed M Elshazly

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 20

Top Topics

Positive Breast Cancer

Estrogen Receptor

Top Venues

Molecular pharmacology

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Ahmed M Elshazly, Uruk Shahin, Sofian Al Shboul, David A Gewirtz, Tareq Saleh
A Conversation with ChatGPT on Contentious Issues in Senescence and Cancer Research. Molecular pharmacology 105 (5) (2024)
Ahmed M Elshazly, Uruk Shahin, Sofian Al Shboul, David A Gewirtz, Tareq Saleh
A Conversation with ChatGPT on Contentious Issues in Senescence and Cancer Research. Molecular pharmacology 105 (5) (2024)
Ahmed M Elshazly, Uruk Shahin, Sofian Al Shboul, David A Gewirtz, Tareq Saleh
A Conversation with ChatGPT on Contentious Issues in Senescence and Cancer Research. Molecular pharmacology 105 (5) (2024)
Ahmed M Elshazly, Uruk Shahin, Sofian Al Shboul, David A Gewirtz, Tareq Saleh
A Conversation with ChatGPT on Contentious Issues in Senescence and Cancer Research. Molecular pharmacology 105 (5) (2024)
Ahmed M Elshazly, Uruk Shahin, Sofian Al Shboul, David A Gewirtz, Tareq Saleh
A conversation with ChatGPT on contentious issues in senescence and cancer research. Molecular pharmacology (2024)
Ahmed M Elshazly, Uruk Shahin, Sofian Al Shboul, David A Gewirtz, Tareq Saleh
A Conversation with ChatGPT on Contentious Issues in Senescence and Cancer Research. Molecular pharmacology 105 (5) (2024)
Ahmed M Elshazly, Aya A Elzahed, David A Gewirtz
Evidence for cytoprotective autophagy in response to HER2-targeted monoclonal antibodies. The Journal of pharmacology and experimental therapeutics (2024)
Ahmed M Elshazly, Jingwen Xu, Nebras Melhem, Alsayed Abdulnaby, Aya A Elzahed, Tareq Saleh, David A Gewirtz
Is Autophagy Targeting a Valid Adjuvant Strategy in Conjunction with Tyrosine Kinase Inhibitors? Cancers 16 (17) (2024)
Ahmed M Elshazly, Uruk Shahin, Sofian Al Shboul, David A Gewirtz, Tareq Saleh
A Conversation with ChatGPT on Contentious Issues in Senescence and Cancer Research. Molecular pharmacology 105 (5) (2024)
Ahmed M Elshazly, David A Gewirtz
Is Autophagy Inhibition in Combination with Temozolomide a Therapeutically Viable Strategy? Cells 12 (4) (2023)
Ahmed M Elshazly, David A Gewirtz
Is Autophagy Inhibition in Combination with Temozolomide a Therapeutically Viable Strategy? Cells 12 (4) (2023)
Ahmed M Elshazly, David A Gewirtz
The Cytoprotective Role of Autophagy in Response to BRAF-Targeted Therapies. International journal of molecular sciences 24 (19) (2023)
Ahmed M Elshazly, David A Gewirtz
Making the Case for Autophagy Inhibition as a Therapeutic Strategy in Combination with Androgen-Targeted Therapies in Prostate Cancer. Cancers 15 (20) (2023)
Ahmed M Elshazly, David A Gewirtz
Cytoprotective, Cytotoxic and Cytostatic Roles of Autophagy in Response to BET Inhibitors. International journal of molecular sciences 24 (16) (2023)
Ahmed M Elshazly, David A Gewirtz
Is Autophagy Inhibition in Combination with Temozolomide a Therapeutically Viable Strategy? Cells 12 (4) (2023)
Ahmed M Elshazly, Melanie M Sinanian, Victoria Neely, Eesha Chakraborty, Muruj A Alshehri, Michael K McGrath, Hisashi Harada, Patricia V Schoenlein, David A Gewirtz
BRD4 Inhibition as a Strategy to Prolong the Response to Standard of Care in Estrogen Receptor-Positive Breast Cancer. Cancers 15 (16) (2023)
Tareq Saleh, Ashraf I Khasawneh, Nisreen Himsawi, Jumana Abu-Raideh, Vera Ejeilat, Ahmed M Elshazly, David A Gewirtz
Senolytic Therapy: A Potential Approach for the Elimination of Oncogene-Induced Senescent HPV-Positive Cells. International journal of molecular sciences 23 (24) (2022)
Tareq Saleh, Ashraf I Khasawneh, Nisreen Himsawi, Jumana Abu-Raideh, Vera Ejeilat, Ahmed M Elshazly, David A Gewirtz
Senolytic Therapy: A Potential Approach for the Elimination of Oncogene-Induced Senescent HPV-Positive Cells. International journal of molecular sciences 23 (24) (2022)
Tareq Saleh, Ashraf I Khasawneh, Nisreen Himsawi, Jumana Abu-Raideh, Vera Ejeilat, Ahmed M Elshazly, David A Gewirtz
Senolytic Therapy: A Potential Approach for the Elimination of Oncogene-Induced Senescent HPV-Positive Cells. International journal of molecular sciences 23 (24) (2022)
Ryan M Finnegan, Ahmed M Elshazly, Patricia V Schoenlein, David A Gewirtz
Therapeutic Potential for Targeting Autophagy in ER+ Breast Cancer. Cancers 14 (17) (2022)